Samples used in the study
Equine samples
Tracheal secretions were collected from 39 (38 male and 1 female) Thoroughbred horses [7+0.2 years (mean+SEM); range 4-12 years]. All horses were housed at the same racing yard and samples were obtained as part of a routine assessment of respiratory health (differential cytology). Residual sample was retained for an ongoing proteomic and transcriptomic study. Sample collection procedures were approved by the Veterinary Ethical Review Committee of the School of Veterinary Medicine, University of Edinburgh, following the relevant guidelines and regulations relating to the provisions of the Animals (Scientific Procedures) Act 1986. All methods reported are in accordance with ARRIVE guidelines (https://arriveguidelines.org) 40. Informed consent was obtained from the trainer for the use of residual sample material. Four BALF samples were collected at the Royal (Dick) School of Veterinary Studies, University of Edinburgh. All horses were clinically healthy and treated according to standard welfare procedures.
Murine samples
Bronchoalveolar lavage fluid were generously provided by Prof Jurgen Schwarze (Medical Research Council Centre for Inflammation Research, University of Edinburgh, UK). Samples were collected from four wild type BALB/c female mice, aged 8-12 weeks, at four days following intranasal administration of UV treated Respiratory syncytial Virus (RSV) as described by Jurgen Schwarze’s et al (2107) 41. These mice represented controls to compare against models of RSV infection for investigating the influence of RSV infection on tight junction integrity. All experimental procedures were carried out in accordance with ARRIVE guidelines (https://arriveguidelines.org)40,41. All experimental protocols were approved by the Ethical Review Committee of the Medical Research Council Centre for Inflammation Research, University of Edinburgh, UK, as previously described 41. All methods were carried out in accordance with relevant guidelines and regulations of the Home Office regulations 41.
Mice were housed
at the Medical Research Council Centre for Inflammation
Research, University of Edinburgh, UK in individually ven-
tilated cages for the duration of the study, and all experi-
mental procedures were carried out in accordance with
Home Office regulations
Mice were housed
at the Medical Research Council Centre for Inflammation
Research, University of Edinburgh, UK in individually ven-
tilated cages for the duration of the study, and all experi-
mental procedures were carried out in accordance with
Home Office regulations
Paediatric samples
Bronchoalveolar lavage fluid was collected from three children, with no evidence of lung disease, who were undergoing planned procedures under general anaesthetic. Children were attending for planned surgical procedures (inguinal hernia and hypospadias repair and developmental dysplasia of the hip repair) and were aged between six months and five years (2.5+1 years old, 2 female, 1 male). Children were sampled at the Royal Hospital for Sick Children Edinburgh as part of the Lower respiratory tract infection Kids Study approved by the South East Scotland Research Ethics Committee 02. Informed consent was obtained from appropriate adult with parental responsibility. The clinical study and all associated procedures were conducted within Good Clinical Practice guidelines and the regulations stipulated by the MHRA (Medicines Healthcare Regulation Agency).
Sample collection
Equine samples
All TW samples were collected one hour following morning exercise (interval training) using a trans-endoscopic technique. Horses were restrained and a nose twitch applied when necessary. A 1500mm working length, 9.2 mm outer diameter video endoscope (2.8mm biopsy channel; Aohua, China), was passed via the ventral nasal meatus to the pharynx and then advanced into the trachea via the rima glottidis. Following assessment of the amount and nature of mucus deposits within the tracheal lumen, approximately 20 mL of sterile 0.9% saline at room temperature was instilled via a catheter passed via the biopsy channel of the endoscope at the proximal aspect of the trachea. The endoscope was then further advanced to the level of the thoracic inlet where the pool of instilled fluid had gravitated. As much fluid as possible was subsequently aspirated via the transendoscopic catheter. Samples were stored on ice and submitted for laboratory analysis at the Roslin Institute and the Royal (Dick) School of Veterinary Studies and processed within 4-5 hours of collection. Three BALF samples were collected at the Royal (Dick) School of Veterinary studies from horses admitted to the hospital, as previously described 42; these procedures were performed for diagnostic purposes, with residual BALF made available for this study with owner consent.
Murine samples
Bronchoalveolar lavage fluid was collected by injecting 1ml of PBS containing protease inhibitor via tracheal cannula – 650-900µl of fluid being retrieved. BALF supernatant was then collected and stored at -80oC till further use.
Paediatric samples
While anaesthetised a suction catheter was inserted blindly down the endotracheal tube and 2ml/kg of 0.9% sodium chloride instilled and around 1ml/kg of fluid being retrieved. Following a short period of time, and without removing the suction catheter, sample was collected by applying 10-15kpa of suction to said catheter. Resultant BALF was spun at 400g at 4oC for 10 minutes, the supernatant collected and then frozen at -80°C for storage and further analysis.
Total and differential cell count and total cell and macrophage isolation for equine tracheal wash samples
Differential cell count
An aliquot of 0.5 ml was submitted to the pathology lab at the Royal (Dick) School of Veterinary Studies for DCC analysis. Differential leucocyte count (minimum of 200 cells) was performed and expressed as a percentage of total non-squamous and non-epithelial nucleated cells. Horses were considered free of inflammatory airway disorders based on the following DCC cut off values: neutrophils <20%.
Total cell isolation
First, a 1ml aliquot of sample was immediately stored at -80°C for future proteomic analyses and the remaining sample incubated for 15 minutes at room temperature in 0.1% dithiothreitol (DTT) to depolymerize secreted mucin. Dithiothreitol has been demonstrated to cause no deleterious effects on human sputum derived cells or interfere with surface marker measurements using flow cytometry. Following gravity filtration through a 70µm pore mesh filter, the sample was centrifuged at 400g for 10min at 4oC. Supernatant was carefully removed, and the cell pellet re-suspended in Dubelcco’s PBS, from which a total cell count (excluding squamous epithelial cells) and cell viability (Trypan Blue exclusion staining) was performed using a haemocytometer. Afterwards, the cell pellet was resuspended in 1ml of Trizol and stored at -80oC for future RNA analysis.
Macrophage isolation
Following total cell isolation, immunomagnetic separation was used to isolate macrophages from DTT treated TW samples from 16 of the 39 animals, using magnetic beads coated with mouse anti-human CD163 antibody (GHI/61, BioLegend, cat no 333605), according to the manufacturer’s instructions. We have previously demonstrated cross-reactivity of this antibody with equine macrophages/monocytes. Briefly, the cells were first stained with a R-Phycoerythrin (PE)-conjugated CD163 primary antibody; subsequently, the cells were magnetically labelled with anti-PE MicroBeads (Miltenyi Biotec, cat no 130-105-639) before the cell suspension was loaded on a MACS® LS Column (Miltenyi Biotec Ltd., cat n0 130-042-401), placed in the magnetic field of a MACS Separator. The magnetically labeled cells were retained within the column, while the un-labeled cells passed through. Following removal of the column from the magnetic field, magnetically retained cells were eluted as the positively selected cell fraction.
Flow cytometry analysis of tracheal wash derived cells
Total TW cells were stained with anti-CD163 antibody against macrophages (BioLegend, Catalogue No. 333605). Cells were also stained with Zombie aqua dye (Biolegend, Catalogue No. 423101) to test for viability. A negative/isotype control was used to control for non-specific binding (PE Mouse IgG1, κ Isotype Ctrl, Biolegend, Catalogue No. 400111). Data were acquired on 10,000 live cell events and cells gated according to size (FSC-A: forward scatter) and granularity (SSC-A: side scatter) after removing artifacts, debris, doublet discrimination and dead cells. Data analysis was performed in FlowJo® v10.5.3 (Tree Star).
RNA analysis of equine tracheal wash derived cells
Total RNA extraction
Total RNA was extracted using a combination of Trizol reagent (Thermo Scientific™, 15596026) and an RNAeasy plus micro kit (Qiagen, cat no 74034), according to manufacturer’s instructions. Briefly, following removal of the supernatant, the remaining cell pellet was lysed by the addition of 1mL Trizol Reagent. Subsequently, 0.2 mL 1-Bromo-3-chloropropane (BCP) (Sigma Aldrich, cat no B9673-200ML) was added per 1 mL of Trizol. The sample was shaken vigorously for approximately 30 sec and left at room temperature for 5 min to allow complete dissociation of nuclear-protein complexes. The homogenate was then centrifuged at 18,000g for 15 min at 40C resulting in the formation of a lower red phenol-chloroform phase, an interphase, and an upper colourless aqueous phase. The aqueous phase contained the RNA and had almost 50% of the volume of the Trizol used, plus the volume of the sample. Following transfer to a clean tube for the precipitation step, 0.5 mL of 70% ethanol was added, the sample stored for 2 hours at -200C and then transferred to an RNeasy spin column and centrifuged at 18,000g for 5 min at 40C. Following centrifugation, the flow through was removed, the RNA washed once with RW1 buffer and DNA treatment was performed using the RNase-Free DNase Set (Qiagen, cat no 79254) according to the manufacturer’s instruction. Due to potential DNA contamination, this step was performed twice and samples were run through gDNA Eliminator Spin Columns twice after the elution step. Afterwards, the RNA membrane was washed with RW1, RPE and 80% ethanol. Finally, RNA was eluted in 20 µl RNase-free water and RNA samples were stored at -80oC until further use.
RNA quality assessment
RNA concentration and purity were measured using ND-1000 Nanodrop spectrophotometer (Thermo Scientific, Wilmington, USA) by measuring absorbance at 260 and 280 nm (A260, and A280 respectively). Purity of RNA was determined using the A260/A280 ratio. A ratio close to two was considered to be indicative of pure RNA. RNA integrity was confirmed with the High Sensitivity RNA ScreenTape system (Agilent Technologies). A RIN number greater than seven was considered appropriate for RT-qPCR and RNAseq analysis.
Protein Analysis
Briefly, an aliquot of 500µl of untreated TW or BALF samples was homogenized in protein extraction buffer (100mM Tris, pH 7.6 and 4%w/v SDS) +1% Halt Protease Inhibitor Cocktail, EDTA-Free (Thermo Scientific, cat no 87785). Following homogenization, samples were centrifuged at 20,000 g for 20 min at 100C. The supernatant containing the solubilized protein was removed and stored at -80oC. Protein concentration of samples was determined using a Micro BCA Protein Assay Kit (Thermo Scientific™, cat no 23235) according to the manufacturer’s instructions. Finally, total protein analysis was carried out for quality control purposes and to determine equivocal protein load between samples. Samples were separated by electrophoresis on gradient gels (NuPAGE 4-12% Bis-Tris Protein Gels, 1.0 mm, 12-well, Fisher Scientific, cat no NP0322BOX) and stained with InstantBlue™ Protein Stain (Expedeon Ltd, cat no ISB1L) as previously described 43. The stained gel was then imaged using the LICOR Odyssey imager to visualise and quantify the total protein load within each lane of the gel using associated Image Studio Software.
Trachea wash sample preparation for LC-MS
Sample preparation for LC-MS was carried out using S-Trap micro spin column digestion protocol (Protifi, Huntington, NY). Samples containing 10 μg of protein, were diluted to 50 μL with lysis buffer (5% SDS in 50-mM TEAB) and reduced with 20mM Dithiothreitol at 95 °C for 10 min. After cooling to room temperature, samples were alkylated in the dark for 30 min with 40 mM of iodoacetamide. This mix was then acidified to 1% phosphoric acid and proteins were precipitated with 350 μL of binding buffer [90% methanol, 100-mM Triethyl ammonium bicarbonate (TEAB)]. This protein suspension was loaded onto S-Trap column columns and centrifuged at 4000×g for 30 s. After four washes with 125 μL of 50-mM TEAB, trypsin (0.5 μg in 50mM TEAB) was added to the trap and incubated overnight. Peptides were then eluted with 80 μL of each of the following: 50-mM TEAB, 0.2% formic acid (FA), and 50% acetonitrile in 0.2% FA with centrifugation at 1000g after each elution step. All elution fractions were pooled and dried under vacuum and cleaned up by stage-tipping 44
LC-MS analysis on tracheal wash samples
NanoflowLC-MS/MS was performed on a micrOTOF-II mass spectrometer (Bruker, Germany) coupled to a RSLCnano LC system (Thermo) following earlier method 45 with minor modifications. Raw spectral data were processed with DataAnalysis (Bruker) software and the resulting peak lists were searched using Mascot 2.4 server (Matrix Science) against Uniprot horse sequence database (Uniprot ID UP000002281), containing 44,485 entries. Precursor and fragment ion mass tolerance were set at 25 ppm and 0.06 Da respectively and false discovery rate was set at < 1% for peptide IDs after searching decoy databases.
Protein function annotation and pathway analysis
As previously described 46, identification of enriched KEGG pathways and biological processes in the protein list was performed with Database for Annotation, Visualization and Integrated Discovery (DAVID) software (v6.8) 27,47,48. KEGG pathway database contains regulatory and metabolic pathways, representing global knowledge on molecular interactions and reaction networks. Pathway analysis was performed using Ingenuity Pathway Analysis (IPA Spring 2021 release, https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis) 28 to infer the functional roles and relationships of the detected proteins.